Walleye Trading’s Anavex Life Sciences AVXL Stock Holding History

Walleye Trading’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$58.9K	Sell	19,200 -800	-4%	-$3.46K	﹤0.01%	3638
2025 Q4	$71.2K	Buy	+20,000	New	+$123K	﹤0.01%	3858
2025 Q2	–	Sell	-11,400	Closed	-$97.8K	–	4216
2025 Q1	$97.8K	Buy	11,400 +1,100	+11%	+$10.4K	﹤0.01%	3393
2024 Q4	$111K	Buy	+10,300	New	+$79.2K	﹤0.01%	3515
2024 Q3	–	Sell	-22,900	Closed	-$96.6K	–	4100
2024 Q2	$96.6K	Sell	22,900 -7,300	-24%	-$29.5K	﹤0.01%	3385
2024 Q1	$154K	Buy	+30,200	New	+$170K	﹤0.01%	3572
2023 Q3	–	Sell	-7,900	Closed	-$64.2K	–	4984
2023 Q2	$64.2K	Sell	7,900 -94,600	-92%	-$811K	﹤0.01%	3890
2023 Q1	$878K	Buy	+102,500	New	+$1.02M	﹤0.01%	2314
2022 Q3	–	Sell	-8,900	Closed	-$89K	–	5023
2022 Q2	$89K	Buy	8,900 +7,700	+642%	+$72.9K	﹤0.01%	4158
2022 Q1	$15K	Buy	+1,200	New	+$14.8K	﹤0.01%	4828
2021 Q4	–	Sell	-8,000	Closed	-$144K	–	5342
2021 Q3	$144K	Buy	8,000 +2,600	+48%	+$51.8K	﹤0.01%	4147
2021 Q2	$123K	Buy	+5,400	New	+$80K	﹤0.01%	4277

Other funds holding AVXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Walleye Trading's AVXL Position: Q1 2024 in Review

Walleye Trading sold out of Anavex Life Sciences (AVXL) in Q1 2024, closing a stake of 20,473 shares — an estimated $115K sold.

Walleye Trading first reported a position in AVXL in Q2 2021 and held it in 4 quarters. The position peaked at $1.4M in Q2 2021. 147 funds tracked by Wall St. Rank hold AVXL as of Q1 2024.

Walleye Trading reported no remaining Anavex Life Sciences position as of Q1 2024 after selling out during the quarter.
Walleye Trading sold 20,473 Anavex Life Sciences shares in Q1 2024, an estimated $115K.
Walleye Trading first reported a position in Anavex Life Sciences in Q2 2021 and held it in 4 quarters.
Walleye Trading's Anavex Life Sciences position peaked at $1.4M in Q2 2021.
147 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.